Breathe BioMedical

Focus: Breathe BioMedical is a diagnostic company specializing in breath analysis technology using infrared spectroscopy to detect oncology and infectious disease biomarkers. The company is based in Cambridge, MA and operates at the early-stage research level with a focus on non-invasive diagnostic innovation.

Oncology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Breathe BioMedical

AI assessmentNot Hiring

No open roles listed right now. Follow Breathe BioMedical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

6 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Identifying Patterns in the Breath of Individuals With Breast Cancer

Breast Cancer

N/A

Clinical Trials (1)

NCT06512350Identifying Patterns in the Breath of Individuals With Breast Cancer

N/A

Help build intelligence for Breathe BioMedical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Ground-floor opportunity in an emerging diagnostic modality (breath analysis) with potential to disrupt oncology screening across multiple cancer types
Cambridge location provides access to world-class research institutions and biotech talent network
Early-stage pipeline spanning lung cancer, breast cancer, and infectious disease indicates diversified commercial potential

Watch Out For

No active job openings currently listed, suggesting limited near-term hiring or possible hiring freeze
All 6 pipeline programs remain in exploratory/pre-clinical phases with no FDA development stage designation, indicating significant de-risking required
Lack of public financial data, employee count, or funding details raises questions about company stability and growth trajectory

Generated by Claude from Breathe BioMedical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy

Lung Cancer

N/A

Clinical Trials (1)

NCT05174468Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy

N/A

Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy

Lung Cancer

N/A

Clinical Trials (1)

NCT04556435Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy

N/A

Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients W

Lung Cancer

N/A

Clinical Trials (1)

NCT06288646Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer

N/A

Breath Analysis of Patients Diagnosed With COVID-19 Using Infrared Spectroscopy

SARS-CoV-2 Infection

N/A

Clinical Trials (1)

NCT04867213Breath Analysis of Patients Diagnosed With COVID-19 Using Infrared Spectroscopy

N/A

Breathe sample

Lung Transplant Rejection

N/A

Clinical Trials (1)

NCT06309628Analysis of Volatile Organic Compounds in the Breath of Lung Transplant Rejection Patients Using Infrared Spectroscopy

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 6 clinical trials

Top TAs: Oncology, Infectious Diseases

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Oncology

4 pipeline

Infectious Diseases

1 pipeline

Marketed

Pipeline